News related to rare disease, including patient stories, new programs and initiatives, and more.
The Neuro is leading a groundbreaking clinical trial testing an RNA-based therapy for Spinocerebellar Ataxia Type 2 (SCA2), with the potential to halt or reverse disease progression.
The Honourable Mark Holland, Canada’s Minister of Health and the Honourable Mark McLane, Minister of Health and Wellness for Prince Edward Island (PEI) announced a $40 million federal investment as part of two bilateral agreements to improve access to medications for Islanders.
On Rare Disease Day 2025, CRDN participated in national events, fostering collaboration, raising awareness, and sharing updates on progress thus far..
CHEO’s groundbreaking ThinkRare algorithm is transforming rare disease diagnosis by flagging young patients who may benefit from genetic testing earlier.
University of Alberta researchers have found that urine testing could help diagnose mitochondrial diseases faster and more accurately, reducing the need for invasive muscle biopsies.
The RDI-Lancet Commission on Rare Diseases has officially launched, co-chaired by CRDN’s own Dr. Kym Boycott, to develop evidence-based policy solutions that enhance healthcare for Persons Living with a Rare Disease (PLWRD) worldwide.
Stay updated with the latest developments and events from the CRDN as we advance rare disease research and care across Canada.
This comprehensive calendar is a one-stop-shop for rare disease-related happenings in Canada and beyond, including webinars, workshops, conferences and more.
Learn more about the inaugural RareKids-CAN conference and how the network is transforming clinical trials for pediatric rare diseases in Canada.
Participate in CRDN’s Social Media Survey to share your valuable insights and help us create content that resonates with the rare disease community in Canada.
